Palavra-chave: T-CELL LYMPHOMA

ALISERTIB FIRST-LINE THERAPY OUTCOME OF PHERIPHERAL EXTRANODAL NATURAL KILLER T-CELL LYMPHOMA PROJECT TREATMENT COHORT STUDY T-CELL BRAZIL PROJECT T-CELL PROJECT PROGNOSIS PROSPECTIVE COHORT RANDOMIZED PHASE III STUDY PRIMARY REFRACTORY TCELL BRAZIL PROJECT PATIENTS FAILING